Cyclo Therapeutics Inc (CYTH)

[JellyDonut]

The aforementioned factors combined with the Company’s first-to-market competitive advantage will provide ample room to establish itself as the dominant market player in the formulation, production and marketing of Aquaplex® and Trappsol® branded cyclodextrin products in the newly identified Value-Added CD marketplace.

CTD Holdings Inc. provides the WORLD's widest range of cyclodextrin-based fine chemicals available from a single source. Through its Sphingo Biotechnology division it develops biopharmaceuticals using cyclodextrins as the active ingredient. The NanoSonic Products division provides industrial quantities of cyclodextrins for high value biotechnology manufacturing applications. The CTD division provides research quantities of cyclodextrins to biotechnology laboratories world-wide.

CTD Holdings, Inc. has been the go to company for over twenty years now for anybody in need of high quality cyclodextrin compounds and expertise. The company has been in operation since 1989 and became a fully reporting public company in May of 1994.

Today, we have the largest catalogue of cyclodextrins in the WORLD and have earned the reputation as the provider of choice for many prestigious institutions and companies alike.